Back to Search
Start Over
Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes
- Source :
- Kidney International Reports, Kidney International Reports, 2021, 6 (3), pp.746-754. ⟨10.1016/j.ekir.2020.12.030⟩, Kidney international reports, vol. 6, no. 3, pp. 746-754, Kidney International Reports, Elsevier, 2021, 6 (3), pp.746-754. ⟨10.1016/j.ekir.2020.12.030⟩
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
-
Abstract
- Introduction Myelodysplastic syndromes (MDS) are characterized by a high prevalence of associated autoimmune manifestations. Kidney involvement has been rarely reported in MDS patients. We report on the spectrum of kidney pathological findings in MDS patients. Methods We retrospectively identified MDS patients who had undergone a kidney biopsy between 2001 and 2019 in nine Swiss and French nephrology centres. Results Nineteen patients (median age 74 years [63-83]) were included. At the time of kidney biopsy, eleven (58%) patients had extra-renal auto-immune manifestations and sixteen (84%) presented with acute kidney injury. Median serum creatinine at diagnosis was 2.8 mg/dL [0.6-8.3] and median urinary protein to creatinine ratio was 1.2 g/g [0.2-11]. Acute tubulo-interstitial nephritis (TIN) was present in seven (37%) patients. Immunofluorescence study in one patient with acute TIN disclosed intense IgG deposits along the tubular basement membrane and Bowman’s capsule. Other kidney pathological features included ANCA-negative pauci-immune necrotizing and crescentic glomerulonephritis (n = 3), membranous nephropathy (n = 2), IgA nephropathy (n = 1), IgA vasculitis (n = 1), immunoglobulin-associated membrano-proliferative glomerulonephritis type I (n=1), crescentic C3 glomerulopathy (n = 1), fibrillary glomerulonephritis (n = 1) and minimal change disease (n = 1). Eleven (58%) patients received immunosuppressive treatments, among whom one developed a severe infectious complication. After a median follow-up of 7 month [1-96], nine (47%) patients had chronic kidney disease stage 3 (n = 6) or 4 (n = 3) and five (26%) progressed to end-stage kidney disease. Three patients died. Conclusions MDS are associated to several autoimmune kidney manifestations, predominantly acute TIN. MDS are to be listed among the potential causes of autoimmune TIN.<br />Graphical abstract
- Subjects :
- Nephrology
medicine.medical_specialty
[SDV]Life Sciences [q-bio]
030232 urology & nephrology
030204 cardiovascular system & hematology
Myelodysplastic syndromes
[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology
Gastroenterology
Nephropathy
03 medical and health sciences
0302 clinical medicine
Membranous nephropathy
Clinical Research
Internal medicine
medicine
Minimal change disease
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
acute tubulointerstitial nephritis
autoimmunity
myelodysplastic syndromes
business.industry
Acute kidney injury
Glomerulonephritis
medicine.disease
[SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology
3. Good health
[SDV] Life Sciences [q-bio]
IgA vasculitis
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Kidney disease
Subjects
Details
- Language :
- English
- ISSN :
- 24680249
- Database :
- OpenAIRE
- Journal :
- Kidney International Reports, Kidney International Reports, 2021, 6 (3), pp.746-754. ⟨10.1016/j.ekir.2020.12.030⟩, Kidney international reports, vol. 6, no. 3, pp. 746-754, Kidney International Reports, Elsevier, 2021, 6 (3), pp.746-754. ⟨10.1016/j.ekir.2020.12.030⟩
- Accession number :
- edsair.doi.dedup.....a822a191e8cc6c69ededca623550966f
- Full Text :
- https://doi.org/10.1016/j.ekir.2020.12.030⟩